{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T18:56:07Z","timestamp":1795114567315,"version":"4.10.3"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T00:00:00Z","timestamp":1762128000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T00:00:00Z","timestamp":1762128000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["31971191"],"award-info":[{"award-number":["31971191"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-025-07254-z","type":"journal-article","created":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T09:56:15Z","timestamp":1762163775000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Fused in Sarcoma (FUS) promotes renal cell carcinoma progression via the KCMF1\/FUS\/CENPT axis and activation of the JNK signaling pathway"],"prefix":"10.1186","volume":"23","author":[{"given":"Zaiqing","family":"Jiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yixin","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunfeng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guanqun","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinbao","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xunhua","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuechuan","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaofeng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianzhen","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zongliang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,3]]},"reference":[{"key":"7254_CR1","doi-asserted-by":"publisher","first-page":"17009","DOI":"10.1038\/nrdp.2017.9","volume":"3","author":"JJ Hsieh","year":"2017","unstructured":"Hsieh JJ, Purdue MP, Signoretti S, Swanton C, Albiges L, Schmidinger M, Heng DY, Larkin J, Ficarra V. Renal cell carcinoma. Nat Rev Dis Primers. 2017;3:17009.","journal-title":"Nat Rev Dis Primers"},{"key":"7254_CR2","doi-asserted-by":"publisher","first-page":"3698","DOI":"10.1016\/j.celrep.2018.06.032","volume":"23","author":"CJ Ricketts","year":"2018","unstructured":"Ricketts CJ, De Cubas AA, Fan H, Smith CC, Lang M, Reznik E, Bowlby R, Gibb EA, Akbani R, Beroukhim R, et al. The cancer genome atlas comprehensive molecular characterization of renal cell carcinoma. Cell Rep. 2018;23:3698.","journal-title":"Cell Rep"},{"key":"7254_CR3","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1038\/s41585-022-00592-3","volume":"19","author":"A Ingels","year":"2022","unstructured":"Ingels A, Campi R, Capitanio U, Amparore D, Bertolo R, Carbonara U, Erdem S, Kara \u00d6, Klatte T, Kriegmair MC, et al. Complementary roles of surgery and systemic treatment in clear cell renal cell carcinoma. Nat Rev Urol. 2022;19:391\u2013418.","journal-title":"Nat Rev Urol"},{"key":"7254_CR4","doi-asserted-by":"crossref","unstructured":"Levone BR, Lenzken SC, Antonaci M, Maiser A, Rapp A, Conte F, Reber S, Mechtersheimer J, Ronchi AE, M\u00fchlemann O, et al. FUS-dependent liquid-liquid phase separation is important for DNA repair initiation. J Cell Biol. 2021;220.","DOI":"10.1083\/jcb.202008030"},{"key":"7254_CR5","doi-asserted-by":"publisher","first-page":"2922","DOI":"10.1093\/brain\/awp214","volume":"132","author":"M Neumann","year":"2009","unstructured":"Neumann M, Rademakers R, Roeber S, Baker M, Kretzschmar HA, Mackenzie IR. A new subtype of frontotemporal Lobar degeneration with FUS pathology. Brain. 2009;132:2922\u201331.","journal-title":"Brain"},{"key":"7254_CR6","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1016\/j.neuron.2013.07.033","volume":"79","author":"SC Ling","year":"2013","unstructured":"Ling SC, Polymenidou M, Cleveland DW. Converging mechanisms in ALS and FTD: disrupted RNA and protein homeostasis. Neuron. 2013;79:416\u201338.","journal-title":"Neuron"},{"key":"7254_CR7","doi-asserted-by":"publisher","first-page":"e50640","DOI":"10.15252\/embr.202050640","volume":"22","author":"MA Brunet","year":"2021","unstructured":"Brunet MA, Jacques JF, Nassari S, Tyzack GE, McGoldrick P, Zinman L, Jean S, Robertson J, Patani R, Roucou X. The FUS gene is dual-coding with both proteins contributing to FUS-mediated toxicity. EMBO Rep. 2021;22:e50640.","journal-title":"EMBO Rep"},{"key":"7254_CR8","doi-asserted-by":"publisher","first-page":"5617","DOI":"10.1007\/s00432-022-04507-y","volume":"149","author":"A Singh","year":"2023","unstructured":"Singh A, Choudhury SD, Singh P, Singh VV, Singh SN, Sharma A. KCMF1 regulates autophagy and ion channels\u2019 function in renal cell carcinoma: a future therapeutic target. J Cancer Res Clin Oncol. 2023;149:5617\u201326.","journal-title":"J Cancer Res Clin Oncol"},{"key":"7254_CR9","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1038\/s41467-020-15279-9","volume":"11","author":"WHM Hoevenaar","year":"2020","unstructured":"Hoevenaar WHM, Janssen A, Quirindongo AI, Ma H, Klaasen SJ, Teixeira A, van Gerwen B, Lansu N, Morsink FHM, Offerhaus GJA, et al. Degree and site of chromosomal instability define its oncogenic potential. Nat Commun. 2020;11:1501.","journal-title":"Nat Commun"},{"key":"7254_CR10","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1038\/s41416-022-02020-0","volume":"128","author":"C N\u00f6ssing","year":"2023","unstructured":"N\u00f6ssing C, Ryan KM. 50 years on and still very much alive: \u2018Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics\u2019. Br J Cancer. 2023;128:426\u201331.","journal-title":"Br J Cancer"},{"key":"7254_CR11","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1038\/35077213","volume":"411","author":"GI Evan","year":"2001","unstructured":"Evan GI, Vousden KH. Proliferation, cell cycle and apoptosis in cancer. Nature. 2001;411:342\u20138.","journal-title":"Nature"},{"key":"7254_CR12","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1186\/s12943-019-1030-2","volume":"18","author":"HT Chen","year":"2019","unstructured":"Chen HT, Liu H, Mao MJ, Tan Y, Mo XQ, Meng XJ, Cao MT, Zhong CY, Liu Y, Shan H, Jiang GM. Crosstalk between autophagy and epithelial-mesenchymal transition and its application in cancer therapy. Mol Cancer. 2019;18:101.","journal-title":"Mol Cancer"},{"key":"7254_CR13","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1016\/j.trecan.2020.06.005","volume":"6","author":"V Ramesh","year":"2020","unstructured":"Ramesh V, Brabletz T, Ceppi P. Targeting EMT in cancer with repurposed metabolic inhibitors. Trends Cancer. 2020;6:942\u201350.","journal-title":"Trends Cancer"},{"key":"7254_CR14","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.ceb.2007.02.001","volume":"19","author":"CR Weston","year":"2007","unstructured":"Weston CR, Davis RJ. The JNK signal transduction pathway. Curr Opin Cell Biol. 2007;19:142\u20139.","journal-title":"Curr Opin Cell Biol"},{"key":"7254_CR15","doi-asserted-by":"publisher","first-page":"154757","DOI":"10.1016\/j.phymed.2023.154757","volume":"114","author":"Y Cheng","year":"2023","unstructured":"Cheng Y, Zhong X, Nie X, Gu H, Wu X, Li R, Wu Y, Lv K, Leung GP, Fu C, et al. Glycyrrhetinic acid suppresses breast cancer metastasis by inhibiting M2-like macrophage polarization via activating JNK1\/2 signaling. Phytomedicine. 2023;114:154757.","journal-title":"Phytomedicine"},{"key":"7254_CR16","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1159\/000489766","volume":"47","author":"CW Wu","year":"2018","unstructured":"Wu CW, Wu YG, Cheng C, Hong ZD, Shi ZM, Lin SQ, Li J, He XY, Zhu AY. Interleukin-33 predicts poor prognosis and promotes renal cell carcinoma cell growth through its receptor ST2 and the JNK signaling pathway. Cell Physiol Biochem. 2018;47:191\u2013200.","journal-title":"Cell Physiol Biochem"},{"key":"7254_CR17","doi-asserted-by":"crossref","unstructured":"Chen YW, Rini BI, Beckermann KE. Emerging targets in clear cell renal cell carcinoma. Cancers (Basel). 2022;14.","DOI":"10.3390\/cancers14194843"},{"key":"7254_CR18","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.ccell.2022.12.001","volume":"41","author":"Y Li","year":"2023","unstructured":"Li Y, Lih TM, Dhanasekaran SM, Mannan R, Chen L, Cieslik M, Wu Y, Lu RJ, Clark DJ, Ko\u0142odziejczak I, et al. Histopathologic and proteogenomic heterogeneity reveals features of clear cell renal cell carcinoma aggressiveness. Cancer Cell. 2023;41:139\u2013e163117.","journal-title":"Cancer Cell"},{"key":"7254_CR19","doi-asserted-by":"publisher","first-page":"2321","DOI":"10.1016\/j.acra.2022.12.002","volume":"30","author":"X Zhang","year":"2023","unstructured":"Zhang X, Zhang G, Xu L, Bai X, Zhang J, Chen L, Lu X, Yu S, Jin Z, Sun H. Prediction of world health organization \/International society of urological pathology (WHO\/ISUP) pathological grading of clear cell renal cell carcinoma by Dual-Layer spectral CT. Acad Radiol. 2023;30:2321\u20138.","journal-title":"Acad Radiol"},{"key":"7254_CR20","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1038\/s41581-020-0301-x","volume":"16","author":"N Dizman","year":"2020","unstructured":"Dizman N, Philip EJ, Pal SK. Genomic profiling in renal cell carcinoma. Nat Rev Nephrol. 2020;16:435\u201351.","journal-title":"Nat Rev Nephrol"},{"key":"7254_CR21","doi-asserted-by":"publisher","first-page":"2988","DOI":"10.1016\/j.cell.2021.04.038","volume":"184","author":"A Obradovic","year":"2021","unstructured":"Obradovic A, Chowdhury N, Haake SM, Ager C, Wang V, Vlahos L, Guo XV, Aggen DH, Rathmell WK, Jonasch E, et al. Single-cell protein activity analysis identifies recurrence-associated renal tumor macrophages. Cell. 2021;184:2988\u2013e30052916.","journal-title":"Cell"},{"key":"7254_CR22","doi-asserted-by":"crossref","unstructured":"Swaminathan G, Rogel-Ayala DG, Armich A, Barreto G. Implications in cancer of nuclear micro RNAs, long non-coding RNAs, and circular RNAs bound by PRC2 and FUS. Cancers (Basel). 2024;16.","DOI":"10.3390\/cancers16050868"},{"key":"7254_CR23","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1038\/s41388-024-02972-y","volume":"43","author":"L Yang","year":"2024","unstructured":"Yang L, Wang M, Wang Y, Zhu Y, Wang J, Wu M, Guo Q, Han X, Pandey V, Wu Z, et al. LINC00460-FUS-MYC feedback loop drives breast cancer metastasis and doxorubicin resistance. Oncogene. 2024;43:1249\u201362.","journal-title":"Oncogene"},{"key":"7254_CR24","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1186\/s11658-024-00610-9","volume":"29","author":"S Ma","year":"2024","unstructured":"Ma S, Xu Y, Qin X, Tao M, Gu X, Shen L, Chen Y, Zheng M, Qin S, Wu G, Ju S. RUNX1, FUS, and ELAVL1-induced circPTPN22 promote gastric cancer cell proliferation, migration, and invasion through miR-6788-5p\/PAK1 axis-mediated autophagy. Cell Mol Biol Lett. 2024;29:95.","journal-title":"Cell Mol Biol Lett"},{"key":"7254_CR25","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1186\/s12967-023-04718-y","volume":"21","author":"R Wang","year":"2023","unstructured":"Wang R, Zhong J, Pan X, Su Z, Xu Y, Zhang M, Chen X, Chen N, Yu T, Zhou Q. A novel intronic circular RNA circFGFR1(int2) up-regulates FGFR1 by recruiting transcriptional activators P65\/FUS and suppressing miR-4687-5p to promote prostate cancer progression. J Transl Med. 2023;21:840.","journal-title":"J Transl Med"},{"key":"7254_CR26","doi-asserted-by":"crossref","unstructured":"Wang N, Yu Y, Wang R, Chen Y, Tang J. mRNA-modified FUS\/NRF2 signalling inhibits ferroptosis and promotes prostate cancer growth. Comput Math Methods Med. 2022;2022:8509626.","DOI":"10.1155\/2022\/8509626"},{"key":"7254_CR27","doi-asserted-by":"publisher","first-page":"28669","DOI":"10.1021\/jacs.4c03420","volume":"146","author":"MD Wang","year":"2024","unstructured":"Wang MD, Yi L, Li Y, Xu R, Hu J, Hou DY, Liu C, Wang H. Homologous peptide foldamer promotes FUS aggregation and triggers cancer cell death. J Am Chem Soc. 2024;146:28669\u201376.","journal-title":"J Am Chem Soc"},{"key":"7254_CR28","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1038\/25292","volume":"396","author":"C Lengauer","year":"1998","unstructured":"Lengauer C, Kinzler KW, Vogelstein B. Genetic instabilities in human cancers. Nature. 1998;396:643\u20139.","journal-title":"Nature"},{"key":"7254_CR29","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1038\/nrc.2016.25","volume":"16","author":"PS Steeg","year":"2016","unstructured":"Steeg PS. Targeting metastasis. Nat Rev Cancer. 2016;16:201\u201318.","journal-title":"Nat Rev Cancer"},{"key":"7254_CR30","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1038\/s41586-020-2969-2","volume":"588","author":"X Jin","year":"2020","unstructured":"Jin X, Demere Z, Nair K, Ali A, Ferraro GB, Natoli T, Deik A, Petronio L, Tang AA, Zhu C, et al. A metastasis map of human cancer cell lines. Nature. 2020;588:331\u20136.","journal-title":"Nature"},{"key":"7254_CR31","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1038\/s41423-020-00630-3","volume":"18","author":"D Bertheloot","year":"2021","unstructured":"Bertheloot D, Latz E, Franklin BS. Necroptosis, pyroptosis and apoptosis: an intricate game of cell death. Cell Mol Immunol. 2021;18:1106\u201321.","journal-title":"Cell Mol Immunol"},{"key":"7254_CR32","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1046\/j.1365-2443.1998.00223.x","volume":"3","author":"Y Tsujimoto","year":"1998","unstructured":"Tsujimoto Y. Role of Bcl-2 family proteins in apoptosis: apoptosomes or mitochondria? Genes Cells. 1998;3:697\u2013707.","journal-title":"Genes Cells"},{"key":"7254_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.canlet.2018.01.068","volume":"420","author":"W Xu","year":"2018","unstructured":"Xu W, Liu H, Liu ZG, Wang HS, Zhang F, Wang H, Zhang J, Chen JJ, Huang HJ, Tan Y, et al. Histone deacetylase inhibitors upregulate snail via Smad2\/3 phosphorylation and stabilization of snail to promote metastasis of hepatoma cells. Cancer Lett. 2018;420:1\u201313.","journal-title":"Cancer Lett"},{"key":"7254_CR34","doi-asserted-by":"publisher","first-page":"942","DOI":"10.7150\/ijbs.65653","volume":"18","author":"M Wang","year":"2022","unstructured":"Wang M, Zhang C, Zheng Q, Ma Z, Qi M, Di G, Ling S, Xu H, Qi B, Yao C, et al. RhoJ facilitates angiogenesis in glioblastoma via JNK\/VEGFR2 mediated activation of PAK and ERK signaling pathways. Int J Biol Sci. 2022;18:942\u201355.","journal-title":"Int J Biol Sci"},{"key":"7254_CR35","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1038\/cdd.2009.152","volume":"17","author":"Z Zhang","year":"2010","unstructured":"Zhang Z, Neiva KG, Lingen MW, Ellis LM, N\u00f6r JE. VEGF-dependent tumor angiogenesis requires inverse and reciprocal regulation of VEGFR1 and VEGFR2. Cell Death Differ. 2010;17:499\u2013512.","journal-title":"Cell Death Differ"},{"key":"7254_CR36","doi-asserted-by":"publisher","first-page":"2498","DOI":"10.1038\/s41467-020-16352-z","volume":"11","author":"M Jewer","year":"2020","unstructured":"Jewer M, Lee L, Leibovitch M, Zhang G, Liu J, Findlay SD, Vincent KM, Tandoc K, Dieters-Castator D, Quail DF, et al. Translational control of breast cancer plasticity. Nat Commun. 2020;11:2498.","journal-title":"Nat Commun"},{"key":"7254_CR37","doi-asserted-by":"publisher","first-page":"2082","DOI":"10.1002\/med.21574","volume":"39","author":"Q Wu","year":"2019","unstructured":"Wu Q, Wu W, Fu B, Shi L, Wang X, Kuca K. JNK signaling in cancer cell survival. Med Res Rev. 2019;39:2082\u2013104.","journal-title":"Med Res Rev"},{"key":"7254_CR38","doi-asserted-by":"crossref","unstructured":"Hammouda MB, Ford AE, Liu Y, Zhang JY. The JNK signaling pathway in inflammatory skin disorders and cancer. Cells. 2020;9.","DOI":"10.3390\/cells9040857"},{"key":"7254_CR39","doi-asserted-by":"publisher","first-page":"5466","DOI":"10.7150\/jca.46351","volume":"11","author":"S Liu","year":"2020","unstructured":"Liu S, Chu B, Cai C, Wu X, Yao W, Wu Z, Yang Z, Li F, Liu Y, Dong P, Gong W. DGCR5 promotes gallbladder cancer by sponging MiR-3619-5p via MEK\/ERK1\/2 and JNK\/p38 MAPK pathways. J Cancer. 2020;11:5466\u201377.","journal-title":"J Cancer"},{"key":"7254_CR40","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1007\/s13402-022-00692-7","volume":"45","author":"H Miao","year":"2022","unstructured":"Miao H, Geng Y, Li Y, Tang S, Feng F, Li W, Li Y, Liu L, Zhang R, Qiu S, et al. Novel protein kinase inhibitor TT-00420 inhibits gallbladder cancer by inhibiting JNK\/JUN-mediated signaling pathway. Cell Oncol (Dordr). 2022;45:689\u2013708.","journal-title":"Cell Oncol (Dordr)"},{"key":"7254_CR41","doi-asserted-by":"publisher","first-page":"216642","DOI":"10.1016\/j.canlet.2024.216642","volume":"586","author":"C Liu","year":"2024","unstructured":"Liu C, Qian X, Yu C, Xia X, Li J, Li Y, Xie Y, Gao G, Song Y, Zhang M, et al. Inhibition of ATM promotes PD-L1 expression by activating JNK\/c-Jun\/TNF-\u03b1 signaling axis in triple-negative breast cancer. Cancer Lett. 2024;586:216642.","journal-title":"Cancer Lett"},{"key":"7254_CR42","doi-asserted-by":"publisher","first-page":"117270","DOI":"10.1016\/j.jep.2023.117270","volume":"319","author":"H Jin","year":"2024","unstructured":"Jin H, Liu C, Liu X, Wang H, Zhang Y, Liu Y, Li J, Yu Z, Liu HX. Huaier suppresses cisplatin resistance in non-small cell lung cancer by inhibiting the JNK\/JUN\/IL-8 signaling pathway. J Ethnopharmacol. 2024;319:117270.","journal-title":"J Ethnopharmacol"},{"key":"7254_CR43","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1042\/BST20110641","volume":"40","author":"C Davies","year":"2012","unstructured":"Davies C, Tournier C. Exploring the function of the JNK (c-Jun N-terminal kinase) signalling pathway in physiological and pathological processes to design novel therapeutic strategies. Biochem Soc Trans. 2012;40:85\u20139.","journal-title":"Biochem Soc Trans"},{"key":"7254_CR44","doi-asserted-by":"publisher","first-page":"829","DOI":"10.3389\/fphys.2017.00829","volume":"8","author":"K Grynberg","year":"2017","unstructured":"Grynberg K, Ma FY, Nikolic-Paterson DJ. The JNK signaling pathway in renal fibrosis. Front Physiol. 2017;8:829.","journal-title":"Front Physiol"},{"key":"7254_CR45","first-page":"528","volume":"12","author":"L Lou","year":"2019","unstructured":"Lou L, Hu D, Chen S, Wang S, Xu Y, Huang Y, Shi Y, Zhang H. Protective role of JNK inhibitor SP600125 in sepsis-induced acute lung injury. Int J Clin Exp Pathol. 2019;12:528\u201338.","journal-title":"Int J Clin Exp Pathol"},{"key":"7254_CR46","doi-asserted-by":"publisher","first-page":"107847","DOI":"10.1016\/j.neuropharm.2019.107847","volume":"164","author":"AN Henderson-Redmond","year":"2020","unstructured":"Henderson-Redmond AN, Nealon CM, Davis BJ, Yuill MB, Sepulveda DE, Blanton HL, Piscura MK, Zee ML, Haskins CP, Marcus DJ, et al. c-Jun N terminal kinase signaling pathways mediate cannabinoid tolerance in an agonist-specific manner. Neuropharmacology. 2020;164:107847.","journal-title":"Neuropharmacology"},{"key":"7254_CR47","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1017\/S1461145713000850","volume":"17","author":"A Urrutia","year":"2014","unstructured":"Urrutia A, Granado N, Gutierrez-Lopez MD, Moratalla R, O\u2019Shea E, Colado MI. The JNK inhibitor, SP600125, potentiates the glial response and cell death induced by methamphetamine in the mouse striatum. Int J Neuropsychopharmacol. 2014;17:235\u201346.","journal-title":"Int J Neuropsychopharmacol"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-025-07254-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-025-07254-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-025-07254-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T11:08:06Z","timestamp":1762168086000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-025-07254-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,3]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["7254"],"URL":"https:\/\/doi.org\/10.1186\/s12967-025-07254-z","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,3]]},"assertion":[{"value":"6 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study protocol underwent review and approval by the ethics committee of the Affiliated Hospital of Qingdao University (Approval Number: QYFY WZLL 29838). This animal study was reviewed and approved by the Laboratory Animal Ethics Committee of the Affiliated Hospital of Qingdao University (Approval Number: AHQU-MAL20241113JZQ).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Institutional review board statement"}},{"value":"Written informed consent was obtained from all participants involved in this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"The authors have no conflicts of interest to declare.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"1207"}}